Summary: Beth Seidenberg, partner at venture firm Kleiner Perkins Caufield & Byers, speaks at length about KPCB's current areas of interest, and its litmus test for projects worth supporting. Seidenberg also offers a case study of a life sciences firm moving from research lab toward market.
